Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>The 2-methylpyrazolo[1,5-a]pyrimidine is a white crystalline solid that is soluble in some organic solvents. It has been shown to have a diffraction pattern that can be identified using x-ray diffraction and powder x-ray methods. The 2-methylpyrazolo[1,5-a]pyrimidine has not yet been synthesized in bulk quantities and only exists as a reaction solution or as a crystallizing agent.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>4-(tert-Butyldimethylsilyloxy)-1-butyne is a monomer that is used in the production of polymers. It has been shown to be an effective treatment for diabetic neuropathy, which is a chronic condition caused by damage to the peripheral nerves. 4-(tert-Butyldimethylsilyloxy)-1-butyne has also been shown to help protect against nerve damage and improve bladder function in rats.</p>

Versatile small molecule scaffold

<p>3-Bromocinnoline is a heterobicyclic, primary amino acid with a carbonyl group. It has been shown to activate cancer cells and may be useful in the treatment of brain infarction. 3-Bromocinnoline has been shown to inhibit the activity of tyrosine kinase, which is involved in many cellular processes including cell growth, differentiation, and proliferation. The stereoisomers of 3-bromocinnoline have been shown to have different effects on protein kinase activity.</p>

<p>3-Ethynyl-quinoline is a palladium ligand that can be used in the synthesis of palladium complexes. It is an electron-rich, nitrogen-containing heterocyclic compound. 3-Ethynyl-quinoline has been shown to bind to matrix-assisted laser desorption/ionization (MALDI) mass spectrometry and provide information about the structure of the molecule. The terminal alkynes are considered mesomeric, which means they can adopt different structures depending on the type of environment they are in. 3-Ethynyl-quinoline can undergo bond cleavage, as shown by mouse liver microsomes and profiles. In addition, this compound has been shown to have dopamine D3 receptor binding activity in vivo.</p>

<p>6-Ethynylquinoline is a biomolecule that has been demonstrated to be efficient in the production of multipolar and dipolar molecules. It is also a quinoline derivative with a quadrupole moment. 6-Ethynylquinoline has been shown to be an analog of quinoline, which can be synthesized from 2-ethynylpyridine and formaldehyde. The compound is also used as a precursor for other compounds such as 3,4-dihydroisoquinolinium iodide (DIQI) and 4,5-dihydronaphthoquinone (DHNQ).</p>

<p>4-Ethynylisoquinoline is a chemical compound that inhibits rho-kinase, an enzyme that plays a role in the formation of blood clots. It has been shown to be effective in inhibiting cerebral vasospasm and potent at inhibiting chloride ion channels. 4-Ethynylisoquinoline is used as a pharmaceutical preparation to treat dysuria, but should not be administered if the patient is dehydrated or has high blood pressure. 4-Ethynylisoquinoline can also be used as an intermediate for the synthesis of other compounds with similar properties, such as piperidine. This chemical compound is synthesized by reacting chlorobenzene with dimethylformamide and pyridine in the presence of heat.</p>